CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Format: Artigo
Jezik:Russo
Izdano: IRBIS LLC 2016-02-01
Serija:Фармакоэкономика
Teme:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Online pristup:https://www.pharmacoeconomics.ru/jour/article/view/130
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items